Profile | GDS2987 / GI_32698741-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 9.5 | 33 |
GSM215244 | HMVEC_vehicle_rep2 | 10.5 | 27 |
GSM215253 | HMVEC_vehicle_rep3 | 24.9 | 59 |
GSM215254 | HMVEC_atorvastatin_rep1 | 32.9 | 61 |
GSM215282 | HMVEC_atorvastatin_rep3 | 15.5 | 35 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 22.6 | 41 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 17.1 | 28 |
GSM215294 | HMVEC_SLx2119_rep1 | 27.3 | 63 |
GSM215295 | HMVEC_SLx2119_rep2 | 1.6 | 3 |
GSM215296 | HMVEC_SLx2119_rep3 | 1.4 | 2 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 32 | 45 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 4.7 | 9 |
GSM215312 | PASMC_atorvastatin_rep2 | 25.2 | 38 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 39.3 | 54 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 5.6 | 11 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 26.4 | 51 |
GSM215331 | Fibroblasts_vehicle_rep2 | 47 | 67 |
GSM215332 | Fibroblasts_vehicle_rep3 | 48 | 69 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 32.7 | 61 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 54.6 | 69 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 45.3 | 66 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 32.8 | 64 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 34.5 | 65 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 45 | 67 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 42.9 | 67 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 25.4 | 55 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 29.1 | 57 |